Biological investigation of Paget cells using immortalized Paget cells
Biological investigation of Paget cells using immortalized Paget cells
批准号:
10670816
负责人:
MORI Osamu
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have obtained cultured Paget cell which showed an extended life span derived from the involved skin of a patient with extramammary Paget's disease. In one culture grown in low calcium media, a colony continued to proliferate and nearly covered the dish. After 40th subculture, the cells became larger in size, and ceased proliferating at 48th subculture. Population doubling time was -50 hours. As tumorigenecity test, tuumor formation was assayed using SCID mice, but, any tumor formation was not observed. Every cell expresses EMA, however, a few cells express carcinoembryonic antigen, and are positive for PAS staining. When cultured in high CィイD1++ィエD1 medium, cells express desmoglein 1 and 3, and stratified. Kratin analysis was done with two-dimensional gel electrophoresis. Keratin subunits K1, 4, 5, 7, 8, 10, 18 were observed. The amount of K14 was small. The chromosomal constitution of immortalized Paget cells was analyzed, and distinct numerical and structural karyotypic alterations were observed. Genomic DNA was isolated from 38th-passage cultured cells, and exons 5, 6, 7, 8 of p53 genes were amplified by polymerase chain reaction. A missense mutation at codon 248 (CGG to CAG) resulting in a Arg to Gln substitution was identified in exon 7, and this may be a reason why the cells could be maintained longer. A p53 mutation alone, however, does not make a cell immortal. Other mutations of as yet undetermined genes in addition to p53 gene are deemed to be necessary for immortallization of human cells. At present, no isolated Paget cell line for biochemical and molecular investigations is available. The cells we obtained might serve as a promising tool for studying the biology of Paget cells, even though they do not represent a cell line.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Osamu MORI, Tadashi KARASHIMA, Keizo MATSUO, Takashi HASHIMOTO, Yotaro KATAKATA: "Cultured Paget cells derived from the involved skin of a patient with extramammary Paget's disease had an extended life span"The Journal of Dermatology. 27(1). 60-63 (2000)
Osamu MORI、Tadashi KARASHIMA、Keizo MATSUO、Takashi HASHIMOTO、Yotaro KATAKATA:“从患有乳房外佩吉特病的患者受累皮肤中培养的佩吉特细胞具有延长的寿命”《皮肤病学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Osamu MORI: "Cultured Paget cells derived from the involved skin of a patient with extramammary Pagets disease had an extended life span."The Journal of Dermatology. 27・1. 60-63 (2000)
Osamu MORI:“来自乳房外佩吉特病患者受累皮肤的培养佩吉特细胞具有延长的寿命。”皮肤病学杂志 27・1 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Osamu MORI: "Cultured Paget cells derived from the involved skin of a patient with extramammary Paget's disease had an extended life span."The Journal of Dermatology. 27(1). 60-63 (2000)
Osamu MORI:“从患有乳房外佩吉特病的患者受累皮肤中提取的培养佩吉特细胞具有延长的寿命。”《皮肤病学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Development of knockout mouse of desmoyokin(AHNAK)and analysis of its functio
-
批准号:11470186
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.87万
-
财政年份:1999
-
负责人:MORI Osamu
-
依托单位:
Apoptosis in mouse follicles during catagen regression
-
批准号:07670975
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:MORI Osamu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
-
批准号:2026JJ81586
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈燕华
-
依托单位:
基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
-
批准号:2026JJ82384
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:颜志鹏
-
依托单位:
APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
-
批准号:JCZRQNB202600696
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究
-
批准号:JCZRLH202601033
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
白藜芦醇通过SIRT1/p53乙酰化调控铁死亡及其在口腔鳞状细胞癌顺铂增敏中的作用研究
-
批准号:2026JJ80394
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毛琛
-
依托单位:
中性粒细胞弹性蛋白酶抑制剂Sivelestat通过CCN2/P53/BNIP3通路改善阿霉素心脏毒性线粒体自噬的分子机制研究
-
批准号:2026JJ30190
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李小平
-
依托单位:
基于“心理应激”从P53/AMPK通路介导线粒体能量代谢研究疏肝健脾解毒方对肝郁型三阴乳腺癌铁死亡作用机制
-
批准号:2026JJ50614
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李琳霈
-
依托单位:
基于miR-218-5p/NDRG4/p53通路研究“阴中隐阳”手法针刺风池 穴治疗青光眼性视神经损伤的作用机制
-
批准号:JCZRLH202600426
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
GINS1通过调控肿瘤干性及PTP4A1/p53信号轴促进非小细胞肺癌发生发展及靶向干预研究
-
批准号:JCZRLH202600663
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
软饮食下Igfbp5调控p53/p21通路诱导颞下颌关节退行性变的机制研究
-
批准号:2026JJ60602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周典
-
依托单位: